← Back to Search

Integrated Telehealth After Stroke Care for Hemorrhagic Stroke (iTASC Trial)

N/A
Waitlist Available
Led By Syeda Imama A. Naqvi, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years or older
have had a stroke and have high blood pressure
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

iTASC Trial Summary

This trial is testing a new way to manage blood pressure for stroke patients remotely to see if it's more effective than usual care. The primary outcome is measuring blood pressure control at 3 months.

Eligible Conditions
  • Stroke
  • Hemorrhagic Stroke
  • Ischemic Stroke
  • High Blood Pressure

iTASC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

iTASC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Difference in systolic blood pressure (SBP) from baseline to 3 months
Mean 24-hr systolic blood pressure (SBP) through remote monitoring at 3 months

iTASC Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group XExperimental Treatment2 Interventions
Patients who have had stroke and high blood pressure will participate in 5 telehealth visits, which will take place over 3 months. In addition, remote BP monitoring will be given.
Group II: Group YActive Control1 Intervention
Patients who have had stroke and high blood pressure will participate in 3 visits with primary care and stroke practitioner.

Find a Location

Who is running the clinical trial?

National Center for Advancing Translational Science (NCATS)NIH
99 Previous Clinical Trials
36,334 Total Patients Enrolled
Columbia UniversityLead Sponsor
1,426 Previous Clinical Trials
2,473,389 Total Patients Enrolled
3 Trials studying Hemorrhagic Stroke
2,052 Patients Enrolled for Hemorrhagic Stroke
National Center for Advancing Translational Sciences (NCATS)NIH
317 Previous Clinical Trials
392,644 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor recruiting participants currently?

"Data on clinicaltrials.gov reveals that, as of September 16th 2021, this specific research project is no longer open for recruitment. First posted on November 1st of last year, 1197 other studies are now available to prospective patients."

Answered by AI
~12 spots leftby Mar 2025